286 related articles for article (PubMed ID: 17990284)
1. Longevity bias in cost-effectiveness analysis.
Liu L; Rettenmaier AJ; Saving TR
Health Econ; 2008 Apr; 17(4):523-34. PubMed ID: 17990284
[TBL] [Abstract][Full Text] [Related]
2. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
[TBL] [Abstract][Full Text] [Related]
3. On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin.
Hansen BO; Hougaard JL; Keiding H; Østerdal LP
J Health Econ; 2004 Sep; 23(5):887-98. PubMed ID: 15353184
[TBL] [Abstract][Full Text] [Related]
4. Toward a broader view of values in cost-effectiveness analysis of health.
Menzel P; Gold MR; Nord E; Pinto-Prades JL; Richardson J; Ubel P
Hastings Cent Rep; 1999; 29(3):7-15. PubMed ID: 10420299
[No Abstract] [Full Text] [Related]
5. [Methods of comparative economic evaluations of therapies and for rational allocation of resources across sectors of health care systems - introduction, advantages, risks].
Wasem J; Hessel F; Kerim-Sade C
Psychiatr Prax; 2001 Jul; 28 Suppl 1():S12-20. PubMed ID: 11533902
[TBL] [Abstract][Full Text] [Related]
6. A note on cost-value analysis.
Østerdal LP
Health Econ; 2003 Mar; 12(3):247-50; discussion 251-3. PubMed ID: 12605468
[TBL] [Abstract][Full Text] [Related]
7. Live long, live well: quantifying the health of heterogeneous populations.
Mullahy J
Health Econ; 2001 Jul; 10(5):429-40. PubMed ID: 11466804
[TBL] [Abstract][Full Text] [Related]
8. Allocating health care resources when people are risk averse with respect to life time.
Hoel M
Health Econ; 2003 Jul; 12(7):601-8. PubMed ID: 12825211
[TBL] [Abstract][Full Text] [Related]
9. Rationing health care resources. Is the quality-adjusted life-year a helpful guide?
Warren JM
Can Fam Physician; 1994 Jan; 40():123-4, 127-8. PubMed ID: 8312748
[TBL] [Abstract][Full Text] [Related]
10. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
Gupta OP; Brown GC; Brown MM
Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
[TBL] [Abstract][Full Text] [Related]
11. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
12. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
Dolan P; Edlin R
J Health Econ; 2002 Sep; 21(5):827-43. PubMed ID: 12349884
[TBL] [Abstract][Full Text] [Related]
13. Application of cost-effectiveness analysis to multiple products: a practical guide.
Bala MV; Zarkin GA
Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
[TBL] [Abstract][Full Text] [Related]
14. Anti-social welfare functions: a reply to Hansen et al.
Edlin R
J Health Econ; 2004 Sep; 23(5):899-905. PubMed ID: 15353185
[TBL] [Abstract][Full Text] [Related]
15. Adjusting to changes in health: implications for cost-effectiveness analysis.
Sharma R; Stano M; Haas M
J Health Econ; 2004 Mar; 23(2):335-51. PubMed ID: 15019760
[TBL] [Abstract][Full Text] [Related]
16. Theory and methods of economic evaluation of health care.
Johannesson M
Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
[No Abstract] [Full Text] [Related]
17. Does it matter who you are or what you gain? An experimental study of preferences for resource allocation.
Schwappach DL
Health Econ; 2003 Apr; 12(4):255-67. PubMed ID: 12652513
[TBL] [Abstract][Full Text] [Related]
18. Evaluating chronic disease for heterogeneous populations: the case of arthritis.
Scharff RL; Jessup A
Med Care; 2007 Sep; 45(9):860-8. PubMed ID: 17712256
[TBL] [Abstract][Full Text] [Related]
19. Equity weights in the allocation of health care: the rank-dependent QALY model.
Bleichrodt H; Diecidue E; Quiggin J
J Health Econ; 2004 Jan; 23(1):157-71. PubMed ID: 15154692
[TBL] [Abstract][Full Text] [Related]
20. Disability Adjusted Life Years (DALYs) and rehabilitation.
Jelsma J; De Weerdt W; De Cock P
Disabil Rehabil; 2002 May; 24(7):378-82. PubMed ID: 12022788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
